Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature

Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myeloma (MM). Despite an excellent improvement in survival for most patients with MM over recent decades, the overall survival (OS) of patients with EMM was usually not longer than 3 years. Standard treatment for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Ying, Qian, Zijun, Zhao, Xiujie, Pan, Wenjue, Wei, Xinzheng, Meng, Huimin, Yang, Lin, Xiao, Haowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138324/
https://www.ncbi.nlm.nih.gov/pubmed/34026784
http://dx.doi.org/10.3389/fmed.2021.649824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138324/
https://www.ncbi.nlm.nih.gov/pubmed/34026784
http://dx.doi.org/10.3389/fmed.2021.649824

Ejemplares similares